Davern Capital Partners, LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Davern Capital Partners, LP held in its portfolio 14 assets valued at $309,295,331 (i.e. $309.30M).

The most valuable assets in the portfolio included: PFIZER INC ($50.85M), REGENERON PHARMACEUTICALS ($40.46M), and BIONTECH SE ($35.34M).

The chart below shows the top 10 valuable assets, and the table below shows the top 14 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Davern Capital Partners, LP Portfolio

PFIZER INC

REGENERON PHARMACEUTICALS

BIONTECH SE

ROYALTY PHARMA PLC

ARGENX SE

LEGEND BIOTECH CORP

ROIVANT SCIENCES LTD

IONIS PHARMACEUTICALS INC

NATERA INC

ELI LILLY & CO

Davern Capital Partners, LP - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
PFIZER INC	2042242	50851826	COM
REGENERON PHARMACEUTICALS	52420	40461425	COM
BIONTECH SE	371216	35339763	SPONSORED ADS
ROYALTY PHARMA PLC	840650	32482716	SHS CLASS A
ARGENX SE	35685	30009301	SPONSORED ADR
LEGEND BIOTECH CORP	1056668	22971962	SPONSORED ADS
ROIVANT SCIENCES LTD	1028298	22314067	SHS
IONIS PHARMACEUTICALS INC	238477	18865915	COM
NATERA INC	78650	18017929	COM
ELI LILLY & CO	8307	8927367	COM
VIRIDIAN THERAPEUTICS INC	261615	8141459	COM
MINERALYS THERAPEUTICS INC	210648	7644416	COM
CG ONCOLOGY INC	162005	6726448	COM
ABIVAX SA	48502	6540737	SPONSORED ADS